Senescent Macrophages in Osteoporosis

The burden of senescent cells increases in later life and contributes to the chronic inflammation and disruption of tissue structure and function that are characteristic of aging. The innate immune cell population of macrophages can enter the senescent state just like other cell types, and are thought to be particularly influential in the pathologies of aging. There has been some debate over the years as to the degree to which early markers of senescence are useful in identifying macrophage senescence, however, and thus whether early studies were correct. It can be challenging to distinguish maladaptively inflammatory macrophages versus senescent macrophages via simple markers of cellular senescence. It remains the case that the research community considers macrophage senescence to be influential in aging; as an example, this review is focused on the contribution of senescent macrophages to osteoporosis, the age-related loss of bone mineral density that arises from disruption to the normal processes of bone maintenance.

Macrophages are highly plastic innate immune cells that contribute to tissue homeostasis, immune surveillance, inflammation resolution, and tissue repair. In bone tissue, macrophages are important components of the bone immune microenvironment and participate in the regulation of bone remodeling through interactions with osteoblasts, osteoclasts, bone marrow mesenchymal stem cell (BMSC), and other stromal or immune cells. Macrophage phenotypes are shaped by local microenvironmental cues and are often simplified into pro-inflammatory M1-like and reparative M2-like states. However, this binary classification does not fully capture macrophage heterogeneity in ageing bone marrow. In particular, macrophages in aged or diseased bone may acquire senescence-associated features that are distinct from ordinary inflammatory activation or classical polarization states.

The accumulating evidence indicates that the imbalance of the bone immune microenvironment is a key pathological process in osteoporosis. Traditionally, studies have focused on the effects of macrophages on the differentiation of osteoblasts or osteoclasts. However, recent discoveries suggest that the status of macrophages is closely related to the interaction of BMSCs within the bone marrow microenvironment and determines different outcomes. Macrophages in young mice can secrete factors that promote the osteogenic differentiation of BMSCs, while this ability is diminished in aged mice. Furthermore, older mice or elderly individuals displayed a marked increase in M1-polarized macrophages, with senescent macrophages exhibiting heightened production of inflammatory mediators.

The precise contribution of macrophage senescence to osteoporosis has only recently begun to be clarified. In this review, we consolidate current evidence on the mechanisms through which macrophage senescence or senescence-associated macrophage dysfunction may contribute to osteoporosis, including autophagy dysregulation, senescence-associated secretory phenotype (SASP)-related factors, lipolytic factors, ageing-related signaling pathways, mitochondrial transfer, and exosome-mediated communication. We also summarize therapeutic strategies related to macrophage senescence or senescence-associated dysfunction in osteoporosis, while emphasizing that many of these mechanisms and interventions are supported by different levels of evidence.

Link: https://doi.org/10.1186/s12979-026-00586-4

Comment Submission

Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.